Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Overbeck

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 4, 2010
High-grade acute organ toxicity as positive prognostic factor in primary radio(chemo)therapy for locally advanced, inoperable head and neck cancerHendrik Andreas Wolff, Jan Bosch, Klaus Jung, et al.
Radiology|February 23, 2011
High-grade acute organ toxicity as positive prognostic factor in adjuvant radiation and chemotherapy for locally advanced head and neck cancerHendrik A Wolff, Benjamin Daldrup, Klaus Jung, et al.
Pharmacogenetics and Genomics|June 15, 2007
Genetic polymorphisms in the amino acid transporters LAT1 and LAT2 in relation to the pharmacokinetics and side effects of melphalanAnnett Kühne, Rolf Kaiser, Markus Schirmer, et al.
Journal of Cancer Research and Clinical Oncology|July 21, 2009
Nasopharyngeal carcinoma in adults: treatment results after long-term follow-up with special reference to adjuvant interferon-beta in undifferentiated carcinomasHendrik Andreas Wolff, Ralph M W Rödel, Bastian Gunawan, et al.
Journal of Cancer Research and Clinical Oncology|December 25, 2008
Toxicity of daily low dose cisplatin in radiochemotherapy for locally advanced head and neck cancerHendrik Andreas Wolff, Tobias Overbeck, Ralph M Roedel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 8, 2025
Impact of radiation dose on immune cells (EDIC) on oncologic outcome in small cell lung cancer (SCLC)Hannah Sophie Penzl, David Alexander Ziegler, Markus Anton Schirmer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 14, 2023
Outcome of First-Line Treatment With Pembrolizumab According to KRAS/TP53 Mutational Status for Nonsquamous Programmed Death-Ligand 1-High (≥50%) NSCLC in the German National Network Genomic Medicine Lung CancerPhilip Bischoff, Martin Reck, Tobias Overbeck, et al.
JAMA Oncology|July 9, 2026
Consolidative Thoracic Radiotherapy With Atezolizumab Maintenance in Extensive-Stage Small Cell Lung Cancer: The Phase 2 TREASURE Randomized Clinical Trial (AIO-TRK-0320)Farastuk Bozorgmehr, Inn Chung, Rouven Behnisch, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 4, 2010
High-grade acute organ toxicity as positive prognostic factor in primary radio(chemo)therapy for locally advanced, inoperable head and neck cancerHendrik Andreas Wolff, Jan Bosch, Klaus Jung, et al.
Radiology|February 23, 2011
High-grade acute organ toxicity as positive prognostic factor in adjuvant radiation and chemotherapy for locally advanced head and neck cancerHendrik A Wolff, Benjamin Daldrup, Klaus Jung, et al.
Pharmacogenetics and Genomics|June 15, 2007
Genetic polymorphisms in the amino acid transporters LAT1 and LAT2 in relation to the pharmacokinetics and side effects of melphalanAnnett Kühne, Rolf Kaiser, Markus Schirmer, et al.
Journal of Cancer Research and Clinical Oncology|July 21, 2009
Nasopharyngeal carcinoma in adults: treatment results after long-term follow-up with special reference to adjuvant interferon-beta in undifferentiated carcinomasHendrik Andreas Wolff, Ralph M W Rödel, Bastian Gunawan, et al.
Journal of Cancer Research and Clinical Oncology|December 25, 2008
Toxicity of daily low dose cisplatin in radiochemotherapy for locally advanced head and neck cancerHendrik Andreas Wolff, Tobias Overbeck, Ralph M Roedel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 8, 2025
Impact of radiation dose on immune cells (EDIC) on oncologic outcome in small cell lung cancer (SCLC)Hannah Sophie Penzl, David Alexander Ziegler, Markus Anton Schirmer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 14, 2023
Outcome of First-Line Treatment With Pembrolizumab According to KRAS/TP53 Mutational Status for Nonsquamous Programmed Death-Ligand 1-High (≥50%) NSCLC in the German National Network Genomic Medicine Lung CancerPhilip Bischoff, Martin Reck, Tobias Overbeck, et al.
JAMA Oncology|July 9, 2026
Consolidative Thoracic Radiotherapy With Atezolizumab Maintenance in Extensive-Stage Small Cell Lung Cancer: The Phase 2 TREASURE Randomized Clinical Trial (AIO-TRK-0320)Farastuk Bozorgmehr, Inn Chung, Rouven Behnisch, et al.
Pageof 2